272332 Responding to new guidelines: Strategies for public health, housing and environmental health professionals and agencies

Wednesday, October 31, 2012 : 12:50 PM - 1:10 PM

David E. Jacobs, PhD , National Center for Healthy Housing, Columbia, MD
State and local health departments and others will ultimately be charged with implementing recommendations from the CDC and be requested to both prevent exposures and respond to children with blood lead levels above the reference value. Revisions to the guidance on childhood lead poisoning present new challenges in how to collaborate with housing, consumer protection, environmental, and other entities to plan and execute successful primary prevention activities. Experiences in several jurisdictions that already intervene at blood lead levels above the reference value will be presented and evaluated. Challenges include adopting true primary prevention by reducing exposures before an elevation in blood lead levels occur, screening those potential exposures, integrating hazard control into existing housing and environmental intervention activities, shortfalls in federal funding and others.

Learning Areas:
Public health or related organizational policy, standards, or other guidelines

Learning Objectives:
Define likely sources and pathways of childhood lead exposure and interventions based on the primary prevention recommendations of the CDC Advisory Committee on Childhood Lead Poisoning Prevention

Keywords: Lead, CDC Guidelines

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the former director of the HUD lead poisoning prevention program and have published numerous scientific studies funded by CDC, HUD, EPA and others. I have collaborated with local and state health, housing and environmental programs to determine how best to coordinate case management activities.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.